How does vns stop seizures

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Vagus nerve stimulation (VNS) stops seizures by delivering mild electrical pulses to the vagus nerve in the neck, which sends signals to the brain to reduce abnormal electrical activity. Approved by the FDA in 1997 for epilepsy treatment, it can reduce seizure frequency by 20-40% in many patients, with some experiencing over 50% reduction after 1-2 years of use. The device is typically implanted under the skin near the collarbone and programmed to deliver stimulation automatically or on-demand.

Key Facts

FDA approved for epilepsy treatment in 1997
Reduces seizure frequency by 20-40% in many patients
Some patients experience over 50% reduction after 1-2 years
Device is implanted under skin near collarbone
Delivers electrical pulses to vagus nerve in neck

Overview

Vagus nerve stimulation (VNS) is a medical treatment for epilepsy that involves implanting a small device to deliver electrical impulses to the vagus nerve. First developed in the 1980s, VNS received FDA approval in 1997 for treating refractory epilepsy in patients aged 12 and older. The vagus nerve is the tenth cranial nerve that runs from the brainstem through the neck to the abdomen, carrying signals between the brain and various organs. Historically, epilepsy treatments focused primarily on medications, but approximately 30% of epilepsy patients don't respond adequately to anti-seizure drugs, creating a need for alternative treatments like VNS. The first human VNS implant was performed in 1988, and by 2020, over 100,000 patients worldwide had received VNS therapy. The treatment represents a significant advancement in neuromodulation approaches to neurological disorders.

How It Works

The VNS system consists of a pulse generator implanted under the skin near the left collarbone and a lead wire attached to the left vagus nerve in the neck. The device delivers mild electrical pulses (typically 0.25-3.5 mA) at programmed intervals, usually 30 seconds of stimulation every 5 minutes, though settings can be customized. When activated, these electrical signals travel along the vagus nerve to the brainstem, then to various brain regions including the thalamus, amygdala, and cerebral cortex. This stimulation appears to modulate brain activity by increasing inhibitory neurotransmitters like GABA and decreasing excitatory neurotransmitters, creating a more stable electrical environment that's less prone to seizure activity. Patients can also activate extra stimulation using a handheld magnet when they feel a seizure coming on, providing on-demand treatment. The exact mechanisms aren't fully understood but likely involve both direct neural modulation and secondary effects on brain chemistry and blood flow.

Why It Matters

VNS matters because it provides a treatment option for the approximately 1 million Americans with drug-resistant epilepsy who don't respond adequately to medications. Unlike brain surgery, VNS is reversible and doesn't involve removing brain tissue. The treatment can significantly improve quality of life by reducing seizure frequency and severity, decreasing emergency room visits, and allowing better medication management. Many patients report improved mood, alertness, and overall functioning. VNS also represents an important step in neuromodulation therapies, paving the way for other nerve stimulation treatments for conditions like depression, migraines, and inflammatory diseases. The technology continues to evolve with newer models offering more precise programming and responsive stimulation based on heart rate changes that often precede seizures.